Genfit upgraded by HC Wainwright & Co. with a new price target
$GNFT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
HC Wainwright & Co. upgraded Genfit from Neutral to Buy and set a new price target of $8.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/20/2021 | $8.00 | Neutral → Buy | HC Wainwright & Co. |
| 9/30/2021 | $8.00 → $7.00 | Neutral | HC Wainwright & Co. |